Novel protein, antisense to ITGAE

Novel protein, antisense to ITGAE (ENSG00000262358) is annotated as a long non-coding RNA gene in current databases and does not encode a receptor, enzyme, or transporter protein. There is no evidence it functions as a molecular target for therapeutic drugs or has demonstrated biological or disease relevance in human health[9]. Its designation as a 'protein' or 'target molecule/receptor' is likely incorrect or misleading, and there may be confusion in database annotation since the antisense relationship typically refers to regulatory non-coding RNAs and not bona fide protein targets[9]. Further research may be necessary to clarify any emerging functions, but at present, it does not conform to canonical molecular target definitions used in drug discovery or basic biology. Key clarification: - This molecule is not currently established as a protein-coding gene, and thus not a receptor, enzyme, transporter, transcription factor, or other classical therapeutic targets. - It is best described as a long non-coding RNA, antisense to the ITGAE gene (Integrin alpha-E).[9] - There are no aliases, functions, disease roles, drugs, mechanisms, biomarkers, or safety concerns documented in scientific databases for ENSG00000262358[9].

Other names

ENSG00000262358